Management of hilum infiltrating tumors of the liver: The impact of experience and standardization on outcome.


Journal

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
ISSN: 1878-3562
Titre abrégé: Dig Liver Dis
Pays: Netherlands
ID NLM: 100958385

Informations de publication

Date de publication:
01 2019
Historique:
received: 05 03 2018
revised: 04 07 2018
accepted: 09 07 2018
pubmed: 18 8 2018
medline: 14 6 2019
entrez: 18 8 2018
Statut: ppublish

Résumé

The primary endpoint of this study was to evaluate the outcome of surgery for perihilar cholangiocarcinoma in a high-volume tertiary referral center. The study population consisted of 196 consecutive patients with histologically confirmed perihilar cholangiocarcinoma-PHC-who were candidates to surgical treatment. Factors affecting postoperative morbidity were evaluated in the whole series (primary endpoint) and after stratification of patients according to the following criteria: (a) perioperative management protocol implementation; (b) monocentric management (secondary endpoint). The postoperative morbidity rate was 51.5% and mortality 4.1%. The most frequent cause of death was postoperative liver failure. At multivariate analysis, factors affecting the risk of morbidity were: side of hepatectomy, liver volume, intraoperative blood loss, preoperative optimization and single-center management. Patients treated according to preoperative optimization protocol, as well as patients with monocentric management experienced a significant reduction of postoperative morbidity. Preoperative optimization and single-center management significantly affected even long term outcome of patients. Despite continuous improvement in the surgical field, hilum-infiltrating tumors still remain associated with therapeutic and management challenges: a correct preoperative management in a tertiary referral center provides a benefit in terms of morbidity and mortality, thus improving long term results.

Sections du résumé

BACKGROUND
The primary endpoint of this study was to evaluate the outcome of surgery for perihilar cholangiocarcinoma in a high-volume tertiary referral center.
METHODS
The study population consisted of 196 consecutive patients with histologically confirmed perihilar cholangiocarcinoma-PHC-who were candidates to surgical treatment. Factors affecting postoperative morbidity were evaluated in the whole series (primary endpoint) and after stratification of patients according to the following criteria: (a) perioperative management protocol implementation; (b) monocentric management (secondary endpoint).
RESULTS
The postoperative morbidity rate was 51.5% and mortality 4.1%. The most frequent cause of death was postoperative liver failure. At multivariate analysis, factors affecting the risk of morbidity were: side of hepatectomy, liver volume, intraoperative blood loss, preoperative optimization and single-center management. Patients treated according to preoperative optimization protocol, as well as patients with monocentric management experienced a significant reduction of postoperative morbidity. Preoperative optimization and single-center management significantly affected even long term outcome of patients.
CONCLUSION
Despite continuous improvement in the surgical field, hilum-infiltrating tumors still remain associated with therapeutic and management challenges: a correct preoperative management in a tertiary referral center provides a benefit in terms of morbidity and mortality, thus improving long term results.

Identifiants

pubmed: 30115572
pii: S1590-8658(18)30817-X
doi: 10.1016/j.dld.2018.07.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

135-141

Informations de copyright

Copyright © 2018. Published by Elsevier Ltd.

Auteurs

Francesca Ratti (F)

Hepatobiliary Surgery Division, Ospedale San Raffaele, Milano, Italy. Electronic address: ratti.francesca@hsr.it.

Federica Cipriani (F)

Hepatobiliary Surgery Division, Ospedale San Raffaele, Milano, Italy.

Guido Fiorentini (G)

Hepatobiliary Surgery Division, Ospedale San Raffaele, Milano, Italy.

Camila Hidalgo Salinas (C)

Hepatobiliary Surgery Division, Ospedale San Raffaele, Milano, Italy.

Marco Catena (M)

Hepatobiliary Surgery Division, Ospedale San Raffaele, Milano, Italy.

Michele Paganelli (M)

Hepatobiliary Surgery Division, Ospedale San Raffaele, Milano, Italy.

Luca Aldrighetti (L)

Hepatobiliary Surgery Division, Ospedale San Raffaele, Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH